Global Cell Therapy Market

Global Cell Therapy Market Size, Share, Growth Analysis, By Use Type(Clinical-use (By Therapeutic Area (Malignancies, Muscoskeletal Disorders), By Therapy Type(Allogenic Therapies, Autologous Therapies), By Product(Consumables, Equipment), By Technology(Viral Vector Technology, Genome Editing Technology) - Industry Forecast 2022-2028


Report ID: SQMG35H2002 | Region: Global | Published Date: October, 2022 | Pages: 157

Global Cell Therapy Market Insights

The global cell therapy market was valued at USD 14.86 Billion in 2021, and it is expected to reach a value of USD 35.95 Billion by 2028, at a CAGR of 13.45% over the forecast period (2022 - 2028).

The growing number of clinical trials for cell-based treatments is driving the cell therapy industry. As a result, there has been a significant increase in worldwide investment in research and clinical translation. The presence of government and commercial funding bodies that are continuously giving funds to assist projects at various phases of clinical trials can be linked to the growing number of ongoing clinical studies.

In addition, advances in the field of regenerative medicine are likely to lead to more effective treatment options for chronic illnesses. Several businesses in emerging areas, such as Canada, are at the vanguard, attempting to profit from the market for cell therapy's untapped potential.

Market snapshot

Global Market Size

USD 14.86 Billion

Largest Segment

Consumables

Fastest Growth

Consumables

Growth Rate

13.45% CAGR

Global Cell Therapy Market 2021-2028 ($ Bn)
Country Share for North America Region- 2021 (%)
Global Cell Therapy Market Size By Product, 2021-2028 ($ Bn)
Global Cell Therapy Market Size By Product, 2021-2028(%)

To get more reports on the above market click here to Buy The Report

Global Cell Therapy Market Segmental Analysis

The global cell therapy market is segmented based on Use-type, Therapy Type, Product, Technology, Application, and Region. Based on Use-type it is categorized into Clinical-use, By Therapeutic Area, Malignancies, Musculoskeletal Disorders, Autoimmune Disorders, Dermatology, By Cell Type, Stem Cell Therapies, BM, Blood, & Umbilical cord-derived Stem Cells, Adipose-derived cells, Non-stem Cell Therapies, Research-use. Based on Therapy Type it is categorized into Allogenic Therapies, Autologous Therapies. Based on Product it is categorized into Consumables, Equipment, Systems, and Software. Based on Technology it is categorized into Viral Vector Technology, Genome Editing Technology, Somatic Cell Technology, Cell Immortalization Technology, Cell Plasticity Technology, and Three-Dimensional Technology. Based on the region it is categorized into North America, Europe, Asia-Pacific, South America, and MEA.

Analysis by Product

The Global Cell Therapy Market is divided into three categories: consumables, equipment, and systems and software. In 2020, the consumables category held the greatest proportion of the cell therapy technologies market. Factors such as increased company investments in developing improved products, as well as government measures to improve cell-based research, are driving the growth of the cell therapy consumables market.

Global Cell Therapy Market By Product, 2021 (%)

To get detailed analysis on other segments, Request For Sample Report

Global Cell Therapy Market Regional Insights

In 2020, North America is expected to have the biggest market share of 42.0%. The existence of a significant number of institutions and institutes involved in stem cell treatment research and development accounts for the region's large share. Five of the eight top colleges in the world are situated in the United States, including Stanford University's Institute for Stem Cell Biology and Regenerative Medicine, Harvard University's Harvard Stem Cell Institute, and Yale University's Yale Stem Cell Center. Over the projected period, the market for cell therapy in the Asia Pacific is expected to develop at a profitable rate. The growing investment by developers and customers in self-education for sophisticated medical therapies is expected to enhance the income generated by the region's expanding economies. In Asian nations, there are a number of stem cell consortiums whose goal is to ensure that R&D activities are well-coordinated and targeted. Furthermore, because of the legal framework's flexibility, patients from Western nations have been spotted migrating to Asian countries for treatment.

Global Cell Therapy Market By Geography, 2021 - 2028
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Global Cell Therapy Market Dynamics

Driver

  • The demand for novel, better medicines for illnesses like cancer and CVD has led to a rise in general research efforts, as well as financing for cell-based research. The Australian government published The Stem Cell Therapies Mission, a 10-year strategy for stem cell research in Australia, in November 2019. Under the Medical Research Future Fund (MRFF), the project would grant USD 102 million (AU$150 million) to encourage stem cell research in order to develop novel medicines. Similarly, Innovate the UK, the UK's innovation agency, awarded USD 269,670 (GBP 267,000) in funding in September 2019 to develop gel stabilization technologies developed by Atelerix, with the first goal of extending the shelf-life of Rexgenero's cell-based therapies for storage and transport at room temperature.

Restraint

  • Despite technological advancements and product development over the last decade, the industry has been hampered by a shortage of skilled personnel to operate complicated devices such as flow cytometers and multi-mode readers. Flow cytometers and spectrophotometers, which are technologically modern and very complicated, create a wide range of data outputs that require skill to analyze and review. According to the National Accrediting Agency for Clinical Laboratory Sciences, there is a global demand-supply mismatch for competent individuals (NAACLS). Over the next decade, the UK and Europe are anticipated to confront a severe shortage of lab capabilities, with medical laboratories among the worst impacted.

Speak to one of our ABIRAW analyst for your custom requirements before the purchase of this report

Global Cell Therapy Market Competitive Landscape

Companies are getting FDA permission for stem cell treatment for a variety of disorders and infections. For example, in September 2020, the FDA granted Stemedica Cell Technologies, Inc. Investigational New Drug permission to undertake phase II studies of intravenously delivered allogeneic MSCs in covid-19 patients. Ischemic-tolerant MSCs have various characteristics that make them an appealing potential biological treatment for COVID-19, including immunomodulatory effects, limited immunogenicity, and the ability to inhibit excessive pro-inflammatory responses.

Top Players' Company Profiles

  • Thermo Fisher Scientific Inc. (US)
  • Merck KGaA (Germany)
  • MaxCyte (US)
  • Danaher Corporation (US)
  • Becton, Dickinson, and Company (US)
  • Lonza Group (Switzerland)
  • Sartorius AG (Germany)
  • Terumo BCT (US)
  • Fresenius Medical Care AG & Co. KGaA (Germany)
  • Avantor, Inc. (US)
  • Bio-Techne Corporation (US)
  • Corning Incorporated (US)
  • FUJIFILM Irvine Scientific (US)
  • MaxCyte (US)

Recent Developments

  • In June 2022, BlueRock Therapeutics completed enrollment in its open-label Phase 1 study that is aimed at evaluating the safety and preliminary efficacy of its investigational cell-based therapy BRT-DA01 for advanced Parkinson’s disease. The therapy is designed to ease motor symptoms in Parkinson’s patients who do not fully respond to regular medications.
  • In May 2022, Novartis received the US FDA approval for Kymriah CAR-T cell therapy for adult patients with relapsed or refractory follicular lymphoma.

Global Cell Therapy Key Market Trends

  • The expansion of the cell therapy market was aided by the growing frequency of chronic illnesses. Chronic illness is defined as a condition that lasts one year or more and requires medical treatment, affects everyday activities, or both, according to the US Centers for Disease Control and Prevention (CDC). It includes heart disease, cancer, diabetes, and Parkinson's disease. Patients with spinal cord injuries, type 1 diabetes, Parkinson's disease (PD), heart disease, cancer, and osteoarthritis may benefit from stem cells.
  • Allogeneic treatments use a single source of cells to treat a large number of people. Immunosuppressive treatments are occasionally used in conjunction with allogeneic goods since they raise the risk of triggering an immunological response in the patient. As a result, increased knowledge regarding the use of cord cells and tissues across many therapeutic domains, as well as increasing physician predisposition toward therapeutic usage of allogeneic treatments, are some of the primary reasons driving the rise.
  • Market growth has also been supported by the steady introduction of new technologies to enable the development of sophisticated treatments. The introduction of proprietary cell lines is often regarded as the most effective way to use a single product to generate a large number of candidates. Immunicum, for example, uses Chimeric Antigen Receptor T cell (CAR-T) growth, dendritic cell neoantigen presentation technology, and T-cell primers to improve its immuno-oncology product line.

Global Cell Therapy Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates and Analyses the Data collected by means of Primary Exploratory Research backed by the robust Secondary Desk research.

According to our analysis, cell-based therapies have the potential to replace, repair, restore, or regenerate damaged tissues and organs. Researchers are investing heavily in the development of such effective and safe treatments as an alternative to conventional treatment strategies, which is attributed to market growth. The timely delivery of therapies to patients at required clinical sites is one of the most pressing issues confronting market participants. Furthermore, the administration of these therapeutics poses a number of post-pandemic challenges. Hospitals are hesitant to provide services due to concerns about SARS-CoV-2 transmission, particularly to vulnerable individuals.

Report Metric Details
Market size value in 2021 USD 14.86 Billion
Market size value in 2028 USD 35.95 Billion
Growth Rate 13.45%
Base year 2021
Forecast period 2022 - 2028
Forecast Unit (Value) USD Billion
Segments covered
  • Use Type
    • Clinical-use (By Therapeutic Area (Malignancies, Muscoskeletal Disorders, Autoimmune Disorders,, Dermatology), By Cell Type (Stem Cell Therapies, Bm, Blood, & Umbilical Cord-derived Stem Cells, Adipose-derived Cells, Non-stem Cell Therapies)), Research-use
  • Therapy Type
    • Allogenic Therapies, Autologous Therapies
  • Product
    • Consumables, Equipment, Systems, Software
  • Technology
    • Viral Vector Technology, Genome Editing Technology, Somatic Cell Technology, Cell Immortalization Technology, Cell Plasticity Technology, Three-dimensional Technology
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Thermo Fisher Scientific Inc. (US)
  • Merck KGaA (Germany)
  • MaxCyte (US)
  • Danaher Corporation (US)
  • Becton, Dickinson, and Company (US)
  • Lonza Group (Switzerland)
  • Sartorius AG (Germany)
  • Terumo BCT (US)
  • Fresenius Medical Care AG & Co. KGaA (Germany)
  • Avantor, Inc. (US)
  • Bio-Techne Corporation (US)
  • Corning Incorporated (US)
  • FUJIFILM Irvine Scientific (US)
  • MaxCyte (US)
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Global Cell Therapy Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Global Cell Therapy Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Global Cell Therapy Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Global Cell Therapy Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Global Cell Therapy Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Global Cell Therapy Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

SPEAK TO AN ANALYST

FAQ's

The global cell therapy market was valued at USD 14.86 Billion in 2021, and it is expected to reach a value of USD 35.95 Billion by 2028, at a CAGR of 13.45% over the forecast period (2022 - 2028).

Companies are getting FDA permission for stem cell treatment for a variety of disorders and infections. For example, in September 2020, the FDA granted Stemedica Cell Technologies, Inc. Investigational New Drug permission to undertake phase II studies of intravenously delivered allogeneic MSCs in covid-19 patients. Ischemic-tolerant MSCs have various characteristics that make them an appealing potential biological treatment for COVID-19, including immunomodulatory effects, limited immunogenicity, and the ability to inhibit excessive pro-inflammatory responses.'Thermo Fisher Scientific Inc. (US)','Merck KGaA (Germany)','MaxCyte (US)','Danaher Corporation (US)','Becton, Dickinson, and Company (US)','Lonza Group (Switzerland)','Sartorius AG (Germany)','Terumo BCT (US)','Fresenius Medical Care AG & Co. KGaA (Germany)','Avantor, Inc. (US)','Bio-Techne Corporation (US)','Corning Incorporated (US)','FUJIFILM Irvine Scientific (US)','MaxCyte (US)'

The demand for novel, better medicines for illnesses like cancer and CVD has led to a rise in general research efforts, as well as financing for cell-based research. The Australian government published The Stem Cell Therapies Mission, a 10-year strategy for stem cell research in Australia, in November 2019. Under the Medical Research Future Fund (MRFF), the project would grant USD 102 million (AU$150 million) to encourage stem cell research in order to develop novel medicines. Similarly, Innovate the UK, the UK's innovation agency, awarded USD 269,670 (GBP 267,000) in funding in September 2019 to develop gel stabilization technologies developed by Atelerix, with the first goal of extending the shelf-life of Rexgenero's cell-based therapies for storage and transport at room temperature.

The expansion of the cell therapy market was aided by the growing frequency of chronic illnesses. Chronic illness is defined as a condition that lasts one year or more and requires medical treatment, affects everyday activities, or both, according to the US Centers for Disease Control and Prevention (CDC). It includes heart disease, cancer, diabetes, and Parkinson's disease. Patients with spinal cord injuries, type 1 diabetes, Parkinson's disease (PD), heart disease, cancer, and osteoarthritis may benefit from stem cells.

In 2020, North America is expected to have the biggest market share of 42.0%. The existence of a significant number of institutions and institutes involved in stem cell treatment research and development accounts for the region's large share. Five of the eight top colleges in the world are situated in the United States, including Stanford University's Institute for Stem Cell Biology and Regenerative Medicine, Harvard University's Harvard Stem Cell Institute, and Yale University's Yale Stem Cell Center. Over the projected period, the market for cell therapy in the Asia Pacific is expected to develop at a profitable rate. The growing investment by developers and customers in self-education for sophisticated medical therapies is expected to enhance the income generated by the region's expanding economies. In Asian nations, there are a number of stem cell consortiums whose goal is to ensure that R&D activities are well-coordinated and targeted. Furthermore, because of the legal framework's flexibility, patients from Western nations have been spotted migrating to Asian countries for treatment.

Speak With Our Analyst

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Cell Therapy Market

Product ID: SQMG35H2002

$5,300
BUY NOW GET SAMPLE